Benjamin Graham fit · Inversión deep-value defensiva
Is CytomX Therapeutics, Inc. (CTMX) a Benjamin Graham Stock?
Meets only 3/7 Graham criteria — likely overpriced or unstable.
22/100
FNo encaja
3/7 criterios cumplidos
Los criterios de Benjamin Graham, aplicados a CTMX
P/E ≤ 15
clave—
P/B ≤ 1.5
clave0.0x
Current ratio ≥ 2
3.6x
Debt / Equity ≤ 1
0.0x
Cómo se valora CTMX en otras estrategias
Datos financieros en vivo
Cap. mercado
$969.17M
PER (TTM)
14.2x
ROIC (TTM)
62.2%
Margen bruto
100.0%
Preguntas frecuentes
What is CTMX's Benjamin Graham fit score?
CTMX scores 22/100 on our Benjamin Graham fit engine — grade F. Meets only 3/7 Graham criteria — likely overpriced or unstable.
Does Benjamin Graham actually own CTMX?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends CTMX.
How often is this score updated?
CTMX's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Benjamin Graham posea o recomiende CTMX personalmente.